# High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals

> **NCT00885703** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 168 (actual)

## Conditions studied

- Cryptococcal Meningitis
- HIV Infections

## Interventions

- **DRUG:** Fluconazole
- **DRUG:** Amphotericin B

## Key facts

- **NCT ID:** NCT00885703
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04-16
- **Primary completion:** 2017-01-12
- **Final completion:** 2017-01-12
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2021-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00885703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00885703, "High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00885703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*